Business Description
Vetnostrum Animal Health Co Ltd
ISIN : TW0006936008
Share Class Description:
TPE:6936: Ordinary SharesTotal Employee Number:
195Compare
Compare
Traded in other countries / regions
6936.Taiwan Index Membership
TSEC Weighted Index IPO Date
2023-03-24Description
Vetnostrum Animal Health Co Ltd is mainly engaged in importing, manufacturing, and selling pharmaceuticals and nutrition supplements for animals, feed additives, and feed. It derives a majority of its revenue from the sale of animal pharmaceuticals, medicated feed additives, and feeds and the rendering of drug testing services. Geographically, the company derives maximum revenue from Taiwan, followed by the USA, Malaysia, and other countries.
Financial Strength
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 16.64 | |||||
Equity-to-Asset | 0.81 | |||||
Debt-to-Equity | 0.02 | |||||
Debt-to-EBITDA | 0.11 | |||||
Interest Coverage | 278.3 | |||||
Piotroski F-Score | 6/9 | |||||
Altman Z-Score | 6.48 | |||||
Beneish M-Score | -2.04 | |||||
WACC vs ROIC | ||||||
Growth Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 2.3 | |||||
3-Year EBITDA Growth Rate | -0.4 | |||||
3-Year EPS without NRI Growth Rate | 2.7 | |||||
3-Year FCF Growth Rate | 30.8 | |||||
3-Year Book Growth Rate | 5.4 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 63.97 | |||||
9-Day RSI | 52.14 | |||||
14-Day RSI | 48.11 | |||||
3-1 Month Momentum % | 0.14 | |||||
6-1 Month Momentum % | -3.36 | |||||
12-1 Month Momentum % | -9.08 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 3.36 | |||||
Quick Ratio | 2.27 | |||||
Cash Ratio | 1.4 | |||||
Days Inventory | 141.88 | |||||
Days Sales Outstanding | 54.14 | |||||
Days Payable | 53.92 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Dividend Yield % | 4.59 | |||||
Dividend Payout Ratio | 0.92 | |||||
Forward Dividend Yield % | 4.59 | |||||
5-Year Yield-on-Cost % | 4.59 | |||||
3-Year Average Share Buyback Ratio | -3.2 | |||||
Shareholder Yield % | -2.77 |
Profitability Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 31.91 | |||||
Operating Margin % | 11.03 | |||||
Net Margin % | 9.1 | |||||
EBITDA Margin % | 16.5 | |||||
FCF Margin % | 18.59 | |||||
OCF Margin % | 20.4 | |||||
ROE % | 10.34 | |||||
ROA % | 8.23 | |||||
ROIC % | 12.23 | |||||
3-Year ROIIC % | -12.5 | |||||
ROC (Joel Greenblatt) % | 16.67 | |||||
ROCE % | 12.64 | |||||
Years of Profitability over Past 10-Year | 7 |
GF Value Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 18.03 | |||||
PE Ratio without NRI | 18.03 | |||||
PS Ratio | 1.66 | |||||
PB Ratio | 1.78 | |||||
Price-to-Tangible-Book | 1.78 | |||||
Price-to-Free-Cash-Flow | 8.99 | |||||
Price-to-Operating-Cash-Flow | 8.19 | |||||
EV-to-EBIT | 12.59 | |||||
EV-to-EBITDA | 8.61 | |||||
EV-to-Revenue | 1.43 | |||||
EV-to-FCF | 7.62 | |||||
Price-to-GF-Value | 0.83 | |||||
Price-to-Graham-Number | 1.19 | |||||
| Price-to-Net-Current-Asset-Value | 3.55 | |||||
| Price-to-Net-Cash | 24.26 | |||||
Earnings Yield (Greenblatt) % | 7.94 | |||||
FCF Yield % | 10.96 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Vetnostrum Animal Health Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil NT$) | 1,416.122 | ||
| EPS (TTM) (NT$) | 1.83 | ||
| Beta | - | ||
| 3-Year Sharpe Ratio | -0.27 | ||
| 3-Year Sortino Ratio | -0.42 | ||
| Volatility % | 10.65 | ||
| 14-Day RSI | 48.11 | ||
| 14-Day ATR (NT$) | 0.473714 | ||
| 20-Day SMA (NT$) | 33.0475 | ||
| 12-1 Month Momentum % | -9.08 | ||
| 52-Week Range (NT$) | 32.15 - 46.2 | ||
| Shares Outstanding (Mil) | 72.8 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 6 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Vetnostrum Animal Health Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Vetnostrum Animal Health Co Ltd Stock Events
| Event | Date | Price (NT$) | ||
|---|---|---|---|---|
| TWD 1.510000 Cash Dividend | 2026-06-09 | 34.30 (+0.88%) | ||
| TWD 1.686762 Cash Dividend | 2025-07-16 | 38.85 (-0.64%) | ||
| TWD 1.040000 Cash Dividend | 2024-07-10 | 35.85 (-0.83%) |
Show
Entries
Vetnostrum Animal Health Co Ltd Frequently Asked Questions
What is Vetnostrum Animal Health Co Ltd(TPE:6936)'s stock price today?
The current price of TPE:6936 is NT$33.00. The 52 week high of TPE:6936 is NT$46.20 and 52 week low is NT$32.15.
When is next earnings date of Vetnostrum Animal Health Co Ltd(TPE:6936)?
The next earnings date of Vetnostrum Animal Health Co Ltd(TPE:6936) is .
Does Vetnostrum Animal Health Co Ltd(TPE:6936) pay dividends? If so, how much?
The Dividend Yield %  of Vetnostrum Animal Health Co Ltd(TPE:6936) is 4.59% (As of Today), Highest Dividend Payout Ratio of Vetnostrum Animal Health Co Ltd(TPE:6936) was 0.93. The lowest was 0.51. And the median was 0.88. The  Forward Dividend Yield % of Vetnostrum Animal Health Co Ltd(TPE:6936) is 4.59%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Vetnostrum Animal Health Co Ltd
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers